nodes	percent_of_prediction	percent_of_DWPC	metapath
Fingolimod—CYP4F2—nephron tubule—nephrolithiasis	0.0449	0.119	CbGeAlD
Fingolimod—CYP4F2—renal system—nephrolithiasis	0.0409	0.108	CbGeAlD
Fingolimod—CYP4F2—kidney—nephrolithiasis	0.0395	0.104	CbGeAlD
Fingolimod—CYP4F2—cortex of kidney—nephrolithiasis	0.0385	0.102	CbGeAlD
Fingolimod—CYP4F12—nephron tubule—nephrolithiasis	0.0334	0.0882	CbGeAlD
Fingolimod—SPHK1—renal system—nephrolithiasis	0.0316	0.0834	CbGeAlD
Fingolimod—SPHK1—kidney—nephrolithiasis	0.0306	0.0807	CbGeAlD
Fingolimod—Atrioventricular block second degree—Hydrochlorothiazide—nephrolithiasis	0.0297	0.192	CcSEcCtD
Fingolimod—CYP4F12—cortex of kidney—nephrolithiasis	0.0286	0.0755	CbGeAlD
Fingolimod—Atrioventricular block complete—Hydrochlorothiazide—nephrolithiasis	0.0243	0.157	CcSEcCtD
Fingolimod—CYP2E1—urine—nephrolithiasis	0.0209	0.0552	CbGeAlD
Fingolimod—CYP4F12—Biological oxidations—SLC26A1—nephrolithiasis	0.0193	0.0414	CbGpPWpGaD
Fingolimod—S1PR4—G alpha (i) signalling events—RGS14—nephrolithiasis	0.019	0.0408	CbGpPWpGaD
Fingolimod—S1PR3—G alpha (i) signalling events—RGS14—nephrolithiasis	0.0183	0.0393	CbGpPWpGaD
Fingolimod—S1PR5—G alpha (i) signalling events—RGS14—nephrolithiasis	0.0183	0.0393	CbGpPWpGaD
Fingolimod—S1PR1—GPCRs, Other—CHRM3—nephrolithiasis	0.0174	0.0372	CbGpPWpGaD
Fingolimod—CYP3A4—urine—nephrolithiasis	0.0168	0.0445	CbGeAlD
Fingolimod—CYP4F2—Biological oxidations—SLC26A1—nephrolithiasis	0.0167	0.0358	CbGpPWpGaD
Fingolimod—S1PR1—G alpha (i) signalling events—RGS14—nephrolithiasis	0.0166	0.0357	CbGpPWpGaD
Fingolimod—CYP2D6—urine—nephrolithiasis	0.0166	0.0437	CbGeAlD
Fingolimod—SPHK1—Beta3 integrin cell surface interactions—SPP1—nephrolithiasis	0.0129	0.0276	CbGpPWpGaD
Fingolimod—Gamma-glutamyltransferase increased—Hydrochlorothiazide—nephrolithiasis	0.0103	0.0667	CcSEcCtD
Fingolimod—S1PR4—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.0074	0.0159	CbGpPWpGaD
Fingolimod—S1PR5—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00712	0.0153	CbGpPWpGaD
Fingolimod—S1PR3—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00712	0.0153	CbGpPWpGaD
Fingolimod—Gastroenteritis—Hydrochlorothiazide—nephrolithiasis	0.00695	0.0449	CcSEcCtD
Fingolimod—S1PR4—GPCR downstream signaling—RGS14—nephrolithiasis	0.00652	0.014	CbGpPWpGaD
Fingolimod—S1PR1—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00646	0.0139	CbGpPWpGaD
Fingolimod—S1PR3—GPCR downstream signaling—RGS14—nephrolithiasis	0.00627	0.0134	CbGpPWpGaD
Fingolimod—S1PR5—GPCR downstream signaling—RGS14—nephrolithiasis	0.00627	0.0134	CbGpPWpGaD
Fingolimod—Migraine—Hydrochlorothiazide—nephrolithiasis	0.00606	0.0392	CcSEcCtD
Fingolimod—S1PR4—Signaling by GPCR—RGS14—nephrolithiasis	0.00592	0.0127	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—RGS14—nephrolithiasis	0.0057	0.0122	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—RGS14—nephrolithiasis	0.0057	0.0122	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—RGS14—nephrolithiasis	0.0057	0.0122	CbGpPWpGaD
Fingolimod—Liver function test abnormal—Hydrochlorothiazide—nephrolithiasis	0.00568	0.0368	CcSEcCtD
Fingolimod—CYP2E1—nephron tubule—nephrolithiasis	0.00563	0.0149	CbGeAlD
Fingolimod—S1PR4—GPCR ligand binding—CHRM3—nephrolithiasis	0.00563	0.0121	CbGpPWpGaD
Fingolimod—Aspartate aminotransferase increased—Hydrochlorothiazide—nephrolithiasis	0.00554	0.0359	CcSEcCtD
Fingolimod—Alanine aminotransferase increased—Hydrochlorothiazide—nephrolithiasis	0.00543	0.0351	CcSEcCtD
Fingolimod—S1PR5—GPCR ligand binding—CHRM3—nephrolithiasis	0.00542	0.0116	CbGpPWpGaD
Fingolimod—S1PR3—GPCR ligand binding—CHRM3—nephrolithiasis	0.00542	0.0116	CbGpPWpGaD
Fingolimod—Influenza—Hydrochlorothiazide—nephrolithiasis	0.00532	0.0344	CcSEcCtD
Fingolimod—S1PR1—Signaling by GPCR—RGS14—nephrolithiasis	0.00517	0.0111	CbGpPWpGaD
Fingolimod—S1PR4—GPCR ligand binding—PTH—nephrolithiasis	0.00515	0.011	CbGpPWpGaD
Fingolimod—CYP2E1—renal system—nephrolithiasis	0.00512	0.0135	CbGeAlD
Fingolimod—S1PR5—GPCR ligand binding—PTH—nephrolithiasis	0.00496	0.0106	CbGpPWpGaD
Fingolimod—S1PR3—GPCR ligand binding—PTH—nephrolithiasis	0.00496	0.0106	CbGpPWpGaD
Fingolimod—CYP2E1—kidney—nephrolithiasis	0.00495	0.0131	CbGeAlD
Fingolimod—S1PR1—GPCR ligand binding—CHRM3—nephrolithiasis	0.00492	0.0106	CbGpPWpGaD
Fingolimod—CYP2E1—cortex of kidney—nephrolithiasis	0.00482	0.0127	CbGeAlD
Fingolimod—Pneumonia—Hydrochlorothiazide—nephrolithiasis	0.00477	0.0309	CcSEcCtD
Fingolimod—S1PR1—GPCR ligand binding—PTH—nephrolithiasis	0.0045	0.00965	CbGpPWpGaD
Fingolimod—Sinusitis—Hydrochlorothiazide—nephrolithiasis	0.00445	0.0288	CcSEcCtD
Fingolimod—S1PR4—GPCR downstream signaling—DGKH—nephrolithiasis	0.0044	0.00944	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—GRHPR—nephrolithiasis	0.00436	0.00935	CbGpPWpGaD
Fingolimod—Bradycardia—Hydrochlorothiazide—nephrolithiasis	0.00434	0.028	CcSEcCtD
Fingolimod—S1PR3—GPCR downstream signaling—DGKH—nephrolithiasis	0.00424	0.00908	CbGpPWpGaD
Fingolimod—S1PR5—GPCR downstream signaling—DGKH—nephrolithiasis	0.00424	0.00908	CbGpPWpGaD
Fingolimod—CYP3A4—renal system—nephrolithiasis	0.00412	0.0109	CbGeAlD
Fingolimod—S1PR4—Signaling Pathways—ADCY10—nephrolithiasis	0.00411	0.00881	CbGpPWpGaD
Fingolimod—CYP2D6—renal system—nephrolithiasis	0.00405	0.0107	CbGeAlD
Fingolimod—S1PR4—Signaling by GPCR—DGKH—nephrolithiasis	0.004	0.00857	CbGpPWpGaD
Fingolimod—CYP3A4—kidney—nephrolithiasis	0.00398	0.0105	CbGeAlD
Fingolimod—S1PR3—Signaling Pathways—ADCY10—nephrolithiasis	0.00396	0.00848	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—ADCY10—nephrolithiasis	0.00396	0.00848	CbGpPWpGaD
Fingolimod—CYP2D6—kidney—nephrolithiasis	0.00392	0.0103	CbGeAlD
Fingolimod—CYP4F12—Metabolism—AGXT—nephrolithiasis	0.00389	0.00833	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—DGKH—nephrolithiasis	0.00385	0.00825	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—DGKH—nephrolithiasis	0.00385	0.00825	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—DGKH—nephrolithiasis	0.00385	0.00825	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—GRHPR—nephrolithiasis	0.00376	0.00807	CbGpPWpGaD
Fingolimod—Alopecia—Hydrochlorothiazide—nephrolithiasis	0.00376	0.0243	CcSEcCtD
Fingolimod—S1PR1—Signaling Pathways—ADCY10—nephrolithiasis	0.00359	0.0077	CbGpPWpGaD
Fingolimod—Back pain—Hydrochlorothiazide—nephrolithiasis	0.00359	0.0232	CcSEcCtD
Fingolimod—S1PR4—Signaling Pathways—RGS14—nephrolithiasis	0.0035	0.00749	CbGpPWpGaD
Fingolimod—Vision blurred—Hydrochlorothiazide—nephrolithiasis	0.00349	0.0226	CcSEcCtD
Fingolimod—S1PR1—Signaling by GPCR—DGKH—nephrolithiasis	0.00349	0.00749	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—RGS14—nephrolithiasis	0.00337	0.00721	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—RGS14—nephrolithiasis	0.00337	0.00721	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—AGXT—nephrolithiasis	0.00336	0.00719	CbGpPWpGaD
Fingolimod—Leukopenia—Hydrochlorothiazide—nephrolithiasis	0.00332	0.0215	CcSEcCtD
Fingolimod—CYP4F12—Metabolism—SLC26A1—nephrolithiasis	0.00331	0.00708	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—APRT—nephrolithiasis	0.00331	0.00708	CbGpPWpGaD
Fingolimod—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.00328	0.0212	CcSEcCtD
Fingolimod—Cough—Hydrochlorothiazide—nephrolithiasis	0.00324	0.0209	CcSEcCtD
Fingolimod—SPHK1—Metabolism—GRHPR—nephrolithiasis	0.00323	0.00693	CbGpPWpGaD
Fingolimod—S1PR4—GPCR downstream signaling—CHRM3—nephrolithiasis	0.00318	0.00682	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—ADCY10—nephrolithiasis	0.00318	0.00682	CbGpPWpGaD
Fingolimod—S1PR3—GPCR downstream signaling—CHRM3—nephrolithiasis	0.00306	0.00657	CbGpPWpGaD
Fingolimod—S1PR5—GPCR downstream signaling—CHRM3—nephrolithiasis	0.00306	0.00657	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—RGS14—nephrolithiasis	0.00306	0.00655	CbGpPWpGaD
Fingolimod—S1PR4—GPCR downstream signaling—PTH—nephrolithiasis	0.00291	0.00624	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—CHRM3—nephrolithiasis	0.00289	0.00619	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—AGXT—nephrolithiasis	0.00288	0.00618	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—SLC26A1—nephrolithiasis	0.00285	0.00611	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—APRT—nephrolithiasis	0.00285	0.00611	CbGpPWpGaD
Fingolimod—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.00283	0.0183	CcSEcCtD
Fingolimod—S1PR3—GPCR downstream signaling—PTH—nephrolithiasis	0.0028	0.00601	CbGpPWpGaD
Fingolimod—S1PR5—GPCR downstream signaling—PTH—nephrolithiasis	0.0028	0.00601	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—CHRM3—nephrolithiasis	0.00278	0.00596	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—CHRM3—nephrolithiasis	0.00278	0.00596	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—CHRM3—nephrolithiasis	0.00278	0.00596	CbGpPWpGaD
Fingolimod—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.00272	0.0176	CcSEcCtD
Fingolimod—SPHK1—Signaling Pathways—RGS14—nephrolithiasis	0.0027	0.0058	CbGpPWpGaD
Fingolimod—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.0027	0.0174	CcSEcCtD
Fingolimod—S1PR4—Signaling by GPCR—PTH—nephrolithiasis	0.00264	0.00567	CbGpPWpGaD
Fingolimod—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.00261	0.0169	CcSEcCtD
Fingolimod—S1PR3—Signaling by GPCR—PTH—nephrolithiasis	0.00254	0.00545	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—PTH—nephrolithiasis	0.00254	0.00545	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—PTH—nephrolithiasis	0.00254	0.00545	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—CHRM3—nephrolithiasis	0.00253	0.00541	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—SLC26A1—nephrolithiasis	0.00245	0.00525	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—APRT—nephrolithiasis	0.00245	0.00525	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—DGKH—nephrolithiasis	0.00236	0.00506	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.00236	0.00506	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—AQP1—nephrolithiasis	0.00236	0.00505	CbGpPWpGaD
Fingolimod—CYP2E1—Biological oxidations—SLC26A1—nephrolithiasis	0.00235	0.00504	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—PTH—nephrolithiasis	0.00231	0.00495	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—DGKH—nephrolithiasis	0.00227	0.00487	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.00227	0.00487	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—DGKH—nephrolithiasis	0.00227	0.00487	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.00227	0.00487	CbGpPWpGaD
Fingolimod—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00217	0.014	CcSEcCtD
Fingolimod—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.00214	0.0138	CcSEcCtD
Fingolimod—CYP4F12—Metabolism—CHRM3—nephrolithiasis	0.00213	0.00456	CbGpPWpGaD
Fingolimod—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00207	0.0134	CcSEcCtD
Fingolimod—S1PR1—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.00206	0.00442	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—DGKH—nephrolithiasis	0.00206	0.00442	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—AQP1—nephrolithiasis	0.00203	0.00436	CbGpPWpGaD
Fingolimod—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.002	0.0129	CcSEcCtD
Fingolimod—Headache—Hydrochlorothiazide—nephrolithiasis	0.0019	0.0123	CcSEcCtD
Fingolimod—CYP4F2—Metabolism—CHRM3—nephrolithiasis	0.00184	0.00394	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.00183	0.00392	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—DGKH—nephrolithiasis	0.00183	0.00392	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—AQP1—nephrolithiasis	0.00175	0.00374	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—CHRM3—nephrolithiasis	0.00171	0.00366	CbGpPWpGaD
Fingolimod—CYP2D6—Biological oxidations—SLC26A1—nephrolithiasis	0.00167	0.00358	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—CHRM3—nephrolithiasis	0.00164	0.00352	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—CHRM3—nephrolithiasis	0.00164	0.00352	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—CHRM3—nephrolithiasis	0.00158	0.00339	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—PTH—nephrolithiasis	0.00156	0.00335	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—PTH—nephrolithiasis	0.0015	0.00322	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—PTH—nephrolithiasis	0.0015	0.00322	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—CHRM3—nephrolithiasis	0.00149	0.0032	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—PTH—nephrolithiasis	0.00136	0.00293	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—CHRM3—nephrolithiasis	0.00132	0.00283	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—PTH—nephrolithiasis	0.00121	0.00259	CbGpPWpGaD
Fingolimod—CYP3A4—Biological oxidations—SLC26A1—nephrolithiasis	0.00109	0.00234	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—SPP1—nephrolithiasis	0.000784	0.00168	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—SPP1—nephrolithiasis	0.000755	0.00162	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—SPP1—nephrolithiasis	0.000755	0.00162	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—SPP1—nephrolithiasis	0.000685	0.00147	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—SPP1—nephrolithiasis	0.000606	0.0013	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—GRHPR—nephrolithiasis	0.000531	0.00114	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—AGXT—nephrolithiasis	0.000473	0.00101	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—SLC26A1—nephrolithiasis	0.000402	0.000862	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—APRT—nephrolithiasis	0.000402	0.000862	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—GRHPR—nephrolithiasis	0.000377	0.000808	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—AGXT—nephrolithiasis	0.000336	0.00072	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—AQP1—nephrolithiasis	0.000287	0.000615	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—SLC26A1—nephrolithiasis	0.000286	0.000612	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—APRT—nephrolithiasis	0.000286	0.000612	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—CHRM3—nephrolithiasis	0.000259	0.000556	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—GRHPR—nephrolithiasis	0.000246	0.000528	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—AGXT—nephrolithiasis	0.00022	0.000471	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—AQP1—nephrolithiasis	0.000203	0.000436	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—SLC26A1—nephrolithiasis	0.000187	0.0004	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—APRT—nephrolithiasis	0.000187	0.0004	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—CHRM3—nephrolithiasis	0.000184	0.000394	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—AQP1—nephrolithiasis	0.000133	0.000285	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—CHRM3—nephrolithiasis	0.00012	0.000258	CbGpPWpGaD
